B1 bradykinin receptor antagonists
US7414134B2 · kind B2 · utility
0Cited by
1References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 11, 2005 |
| Grant date | Aug 19, 2008 |
| Priority date | — |
| Expiry date | Oct 11, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention encompasses novel compounds and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for treatment of diseases mediated by B1 bradykinin receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.